Cited by 65Pharmacovigilance and Adverse Drug ReactionsParasitic infections in humans and animalsParasitic Diseases Research and Treatment

Albendazole and Praziquantel: Review and Safety Monitoring in Korea

Open access
Hong, Sung-Tae·2018·Infection & Chemotherapy

Abstract

Albendazole (ADZ) and praziquantel (PZQT) have been used as anthelmintics for over 30 years. Worldwide, hundreds of millions tablets are administered to people and livestock every year. ADZ is poorly orally absorbed (<5%), and its uptake is enhanced by high-fat meals, while PZQT is well absorbed (>75%) and uptake is enhanced by carbohydrate-rich meals. Both ADZ and PZQT are safe, but not recommended for children <2 years or for women in the first trimester of pregnancy. Serious adverse events occur following high dose and prolonged administration of these drugs for treatment of echinococcosis or neurocysticercosis, especially in patients with poor liver function. The adverse events may be induced by the drugs, or by the dead worms themselves. The Korea Institute of Drug Safety & Risk Management monitors drug-related adverse events in Korea, and its database included 256 probable or possible ADZ-associated events and 108 PZQT-associated events between 2006 and 2015. Such low incidence rates in Korea are due to the low single dose treatments of ADZ, and the short-term use of PZQT. The number of serious adverse events due to drug interaction induced by ADZ and PZQT were six and two, respectively. We conclude that ADZ and PZQT are generally safe drugs, but they must be used with caution in people with poor liver function or those being comedicated for gastroesophageal reflux disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3947/ic.2018.50.1.1

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Albendazole is contraindicated during pregnancy in humans.

    “Albendazole is contraindicated during pregnancy in humans [3,11].”

    From Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update (2021) · cites this paper as [11]

    The Abstract and Conclusion say albendazole is not recommended in the first trimester, which supports avoiding it during part of pregnancy. But “Drug safety in pregnancy” says WHO has approved its use during pregnancy and describes it as sufficiently safe for certain uses; the paper does not support a blanket contraindication throughout pregnancy. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hong, S.-T.
Affiliations
Seoul National University (KR)
Corresponding author
Hong, Sung-Tae
Venue
Infection & Chemotherapy
Publisher
XMLink
Published
2018
Volume
50
Issue
1
Pages
1
ISSN
  • 1598-8112 (ISSN-L)
  • 2093-2340
  • 2092-6448
OpenAlex
W2793672935
Cited by
65
References
32
Citations by year
2026: 7 · 2025: 4 · 2024: 5 · 2023: 9 · 2022: 13 · 2021: 8 · 2020: 9 · 2019: 10
FWCI
1.14
Type
journal article
Language
en
Open access
Locations
  • Infection and Chemotherapy (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
Seoul National University Hospital
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Parasitic infections in humans and animals
  • Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
Keywords
albendazole, praziquantel, anthelmintics, drug safety, adverse drug reactions, drug interactions, echinococcosis, neurocysticercosis, liver function, gastroesophageal reflux disease, pregnancy contraindication

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review